Speaker Profile
Ph.D., CEO and Co-Founder, Prism AI Therapeutics
Biography
Experienced entrepreneur, scientist, and executive with over 20 years of product development, business development, and team management in the defense and life science industries. Previously, Dr. Zviran was the Co-Founder, CEO CSO of C2i Genomics, leading the company from an academy spin-off to a global commercial leader and to a successful exit. As a former cancer survivor, Asaf is committed to improving cancer patients' quality of life and outcomes.
Talk
Solving the Small and Noisy Multi-Omics Data Problem
We will present an end-to-end solution for the development of AI-driven precision therapeutics. Our quantum-based AI/ML is uniquely able to discover mechanistically interpretable disease models, and correctly discover biomarkers and drug targets. All from small-cohort, real-life and noisy, high-dimensional multi-omics clinical data. Our platform provides a comprehensive end-to-end service, encompassing global sourcing of clinically annotated biospecimens and molecular lab processing with federated-learning insight generation.
AI and Data Sciences Showcase:
Prism AI Therapeutics
Prism AI uses quantum mechanics-based AI/ML to accelerate the development of precision therapeutics for our biotech customers.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
